TScan Therapeutics (TCRX) stock: insider trades, news & valuation
Net buyingShare price and insider trades
TScan Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $140K and 0 sold $0 of TCRX stock on the open market.
Get emailed when insiders cluster-buy stocks like TCRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TCRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $146K | 3 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 TScan Therapeutics, Inc. insider reported open-market purchases totaling $140K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Lynx1 Capital Management Lp (10% Owner) has the highest Insider Score at 89.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Dec 23SEC | Lynx1 Capital Management Lp10% Owner | Buy | 80,0697,937,416 held (+1%) | $0.90 | $72K | -73.6% | 89 |
| Dec 23SEC | Lynx1 Capital Management Lp10% Owner | Buy | 75,5008,012,916 held (+1%) | $0.90 | $68K | -73.6% | 89 |
| Dec 23SEC | Lynx1 Capital Management Lp10% Owner | Buy | 6,2328,019,148 held (+0%) | $0.90 | $6K | -73.6% | 89 |
Insiders at TScan Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Lynx1 Capital Management Lp10% Owner | $146K | — | Dec 23, 2025 | 89 |
TCRX stock: common questions
Are TScan Therapeutics, Inc. insiders buying TCRX stock?
In the past 12 months, 1 insiders reported open-market purchases of TCRX worth $140K. The latest was 10% Owner Lynx1 Capital Management Lp bought $72K of TCRX at $0.90 — first open-market purchase in our records.
Are TScan Therapeutics, Inc. insiders selling TCRX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TCRX's 52-week range?
Over the past year TCRX has traded between $0.23 and $2.52. It last closed at $0.24 on Oct 9, 2026.